Gilead Sciences, Inc.

FDA inspection history in Foster City, California, 2003 to 2024

6
Form 483s
1
Warning letter

Every document, by year

  • Form 483
  • Warning letter

2003: one warning letter; 2011: two Form 483s; 2013: one Form 483; 2018: one Form 483; 2020: one Form 483; 2024: one Form 483.

The story so far

Built from the dates and citations on the documents themselves.

  1. 2003One warning letter, at Foster City, California.
  2. 2011–13Three Form 483s, at Foster City, California.
  3. 2013The longest 483 on file: 9 observations over 10 pages at Foster City, California.
  4. 2018–20Two Form 483s, at Foster City, California.
  5. 2024One Form 483, at Foster City, California.

Cited most

Across all Gilead Sciences observations on file

The complete Gilead Sciences file.

All 7 documents as original PDFs, in one order. For supplier audits, diligence and inspection prep.

$589$693

15% off buying them one by one

Sites

Documents

7 on file, newest first
DateDocumentPrice
2024-01-22483 Form 483$99
2020-07-22483 Form 483$99
2018-07-17483 Form 483$99
2013-04-26483 Form 483$99
2011-12-09483 Form 483$99
2011-10-18483 Form 483$99
2003-07-29Warning letter Warning letter$99

FEI number 1000523075 · most recent document Jan 22, 2024

About Gilead Sciences, Inc.

How many FDA Form 483s has Gilead Sciences, Inc. received?

FDA Intel has 6 Form 483s on file for Gilead Sciences, Inc.; the most recent is dated Jan 22, 2024.

When was Gilead Sciences, Inc. last inspected by FDA?

The most recent FDA inspection document on file for Gilead Sciences, Inc. is a Form 483 dated Jan 22, 2024, for the site in Foster City, California.

What did FDA cite at Gilead Sciences, Inc.?

The regulations cited most in the observations on file for Gilead Sciences, Inc. are 21 CFR 211.160 (General requirements), 3 times; 21 CFR 211.194 (Laboratory records), 2 times; 21 CFR 314.80(c)(1)(i) (Postmarketing reporting of adverse drug experiences), 2 times.

Has Gilead Sciences, Inc. received an FDA warning letter?

Yes. FDA Intel has 1 FDA warning letter on file for Gilead Sciences, Inc.; the most recent is dated Jul 29, 2003.